Indo Us Bio-Tech - News

NSE: INDOUS | BSE: 541304

₹79.09

₹-0.38 (-0.48%)

As on 01-Sep-2026 15:56IST

Market cap

₹157 Cr

Revenue (TTM)

₹113 Cr

P/E Ratio

13.7

P/B Ratio

1.6

Div. Yield

0 %

Annual Reports

Annual Reports

2025

Annual Reports

2024

Annual Reports

2023

Annual Reports

2022

Annual Reports

2021

Annual Reports

2020

Annual Reports

2019

Annual Reports

2018

Annual Reports

2017

Announcements

View Announcements

Recent

Important

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Aug-2026

Results- Financial Results For June 30 2026

12-Aug-2026

Board Meeting Outcome for Outcome Of Board Meeting Held On August 12 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

12-Aug-2026

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

05-Aug-2026

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

05-Aug-2026

Board Meeting Intimation for (A) The Unaudited Financial Results For The Quarter Ended On June 30 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015; (B) Other Corporate Matters.

04-Aug-2026

Revised Outcome Of The Board Meeting Held On 10 July 2026. Reconstitution Of Committees.

15-Jul-2026

Revised: Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015. Ref.: Mail From [email protected] On 13.07.2026 Subject: Resignation Of Statutory Auditor And Appointment Of New Statutory Auditor. Resubmitting The Details As Per Attached SEBI Circular Dated October 18 2019 Through BSE Listing Centre.

15-Jul-2026

Board Meeting Outcome for Change In Composition Of Committees Of The Board.Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

10-Jul-2026

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Jul-2026